| 期 |
标题 |
文件 |
| 卷 71, 编号 2 (2022) |
Application of vitamin D, Russian drug Osteo-Vit D3 in the complex prevention of osteoporosis and osteoporotic fractures in children and teenagers |
|
|
Dedov D.
|
| 卷 68, 编号 3 (2019) |
Use of cluster analysis for the classification of perfumes and cosmetics, which are pharmacy assortment products |
|
|
Fitisova A., Narkevich I., Nemyatykh O., Umarov S.
|
| 卷 71, 编号 3 (2022) |
Application of the gas chromatography-mass spectrometry method for the identification of standard samples of ACE inhibitors drugs |
|
|
Chepilo D., Gegechkori V., Shchepochkina O., Chadova N., Levko A., Shestakov V.
|
| 卷 68, 编号 8 (2019) |
Use of fluorescence staining technique for identification of microorganisms in pharmaceutical analysis |
|
|
Gunar O., Sakhno N., Roshchina M.
|
| 卷 72, 编号 7 (2023) |
Application of proteomic analysis for identification of the pharmaceutical substance pancreatin in developing a reference standard |
|
|
Gegechkori V., Shatilina A., Shchepochkina O., Panchenko O., Kuzina V.
|
| 卷 69, 编号 6 (2020) |
The uncertainty principle in biology and medicine |
|
|
Nesterenko V.
|
| 卷 71, 编号 7 (2022) |
Probiotics on the Russian pharmaceutical market |
|
|
Molokhova E., Tarasevich V., Lipin D.
|
| 卷 70, 编号 8 (2021) |
The problem of a unified approach to certifying standard samples for drug quality control |
|
|
Zhigalina A., Strelova O., Kotova N., Malakhova A., Tsekhanskaya E.
|
| 卷 69, 编号 7 (2020) |
Problems of biological therapy for rheumatic diseases |
|
|
Shakirova D., Ugoltsova V., Abdulganieva D., Safiullin R., Yarkaeva F.
|
| 卷 69, 编号 6 (2020) |
Problems of the segment of medicines for children in pharmacy organizations |
|
|
Soldatov V.
|
| 卷 73, 编号 3 (2024) |
Profile of phenolic compounds of the herb of some species of the genus Artemisia L. |
|
|
Romanteeva Y.
|
| 卷 68, 编号 6 (2019) |
Development of the Russian pharmaceutical market, by using the index analysis |
|
|
Trofimova E., Denisova M., Orlov A.
|
| 卷 70, 编号 8 (2021) |
Development of a bioanalytical procedure for determination of a new antioxidant by a voltammetric method |
|
|
Shinko T., Terentyeva S., Ivanovskaya E., Prosenko O.
|
| 卷 68, 编号 4 (2019) |
DEVELOPMENT OF A HIGHLY EFFICIENT TECHNOLOGY FOR PURIFICATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR |
|
|
Chashchinova D., Shamonov N., Vassarays R., Kudlay D.
|
| 卷 69, 编号 1 (2020) |
Design of Iceland moss (Cetraria islandica) gel for topical use |
|
|
Frolova V., Krishtanova N., Klimkina E., Tikhomirova O.
|
| 卷 69, 编号 7 (2020) |
Design and analysis of a liposomal melatonin formulation for intravenous administration |
|
|
Ageev V., Kulikov O., Gurevich K., Shlyapkina V., Zaborovsky A.
|
| 卷 73, 编号 3 (2024) |
Development and validation of a methodology for the quantitative determination of vitamin D3 in tablets |
|
|
Gutnova T., Kompantsev D., Kisieva M., Potupchik T.
|
| 卷 68, 编号 7 (2019) |
DEVELOPMENT AND VALIDATION OF A PROCEDURE FOR ASSAY OF A NEW SUBSTANCE |
|
|
Mishchenko E., Lazaryan J., Ozerov A.
|
| 卷 72, 编号 5 (2023) |
Development and implementation of a methodology for integrated assessment and prediction of non-compliance risk for HIV-infected patients |
|
|
Petrov A., Glembotskay G., Khoroshilova O., Semenikhin V.
|
| 卷 72, 编号 8 (2023) |
Development and standardization of lozenges containing furosemide |
|
|
Zilfikarov I., Arutyunov A., Lebedeva A., Bochkareva I., Artemyeva V.
|
| 卷 69, 编号 2 (2020) |
Design of capsules with dry corn extract |
|
|
Dvornikova L., Turetskova V., Korenovsky Y.
|
| 卷 72, 编号 3 (2023) |
Development of analysis methods and study of antimicrobial activity of vaginal suppositories with chlorophyllipt |
|
|
Kishchenko V., Zilfikarova E., Zilfikarov I., Boyko N., Bochkareva I., Arutyunov A., Ibragimov T.
|
| 卷 69, 编号 6 (2020) |
Development of a procedure for standardization of the Rozmatin substance from Moldavian dragonhead (Dracocephalum moldavice) herb |
|
|
Zvezdina E., Sheichenko O., Burova A.
|
| 卷 69, 编号 1 (2020) |
Development of a procedure for quantification of the total flavonoid content in the ground burnut (Tribulus terrestris) herb |
|
|
Affuf A., Gileva A., Blinova O., Belonogova V., Turyshev A.
|
| 卷 72, 编号 1 (2023) |
Development of procedure for quantitative determination of triterpenoids and phytosterols in capsules with sabal palm fruit extract |
|
|
Khodakova S., Zilfikarov I., Babaeva E.
|
| 卷 72, 编号 8 (2023) |
Development of a method for the quantitative determination of flavonoids in dill herb (Anethum graveolentis herba) |
|
|
Bourakba S., Marakhova A., Zhilkina V., Bokov D.
|
| 卷 72, 编号 1 (2023) |
Development of a methodology for the quantitative determination of essential oils using peroxic acids |
|
|
Agafonov A., Remezova I., Anosova L.
|
| 卷 72, 编号 2 (2023) |
Development of a model composition of the liposomal form of gefitinib |
|
|
Burdaev N., Nikolaeva L., Shprakh Z., Bunyatyan N., Lantsova A., Sanarova E., Kosenko V.
|
| 卷 71, 编号 7 (2022) |
Development of a domestic standard sample of vitamin D based on comparative studies of its stability |
|
|
Susyev E., Stepanova E., Noskova V.
|
| 卷 69, 编号 7 (2020) |
Elaboration of approaches to standardizing walnut (Juglans regia) leaves |
|
|
Zimenkina N., Kurkin V.
|
| 卷 69, 编号 6 (2020) |
Elaboration of approaches to standardizing Emerson’s thorn (Crataegus submollis) fruits |
|
|
Shaikhutdinov I., Kurkin V., Pravdivtseva O.
|
| 卷 72, 编号 6 (2023) |
Development of approaches to standardization of the herb of the meadowsweet |
|
|
Sokolov N., Kurkin V., Sharipova S., Sazanova K.
|
| 卷 68, 编号 4 (2019) |
ELABORATION OF APPROACHES TO STANDARDIZING WILD BERGAMOT (MONARDA FISTULOSA L.) HERB |
|
|
Lapina A., Kurkin V.
|
| 卷 71, 编号 4 (2022) |
Development of approaches to standardization of achillea millefolium herbs |
|
|
Vaskova A., Kurkin V.
|
| 卷 70, 编号 8 (2021) |
Elaboration of approaches to standardizing love-in-a-mist (Nigella sativa) herb |
|
|
Mubinov A., Kurkin V., Avdeeva E.
|
| 卷 70, 编号 3 (2021) |
ELABORATION OF APPROACHES TO STANDARDIZING THE COMMON LILAC (SYRINGA VULGARIS) FLOWERS |
|
|
Serebryakova A., Kurkin V.
|
| 卷 70, 编号 1 (2021) |
Development of quality indicators for an ethanol infusion in a glucose solution as an antidote for surrogate alcohol poisonings |
|
|
Grigoryeva M., Abrosimova O., Strelova O., Ilyina T., Grebenyuk A.
|
| 卷 70, 编号 5 (2021) |
Elaboration of regulatory approaches to managing the risk of the use of biomedical cell products in the Russian Federation |
|
|
Taube A., Alyautdin R., Merkulov V., Melnikova E., Goryachev D.
|
| 卷 72, 编号 5 (2023) |
Sorption technology for the isolation of pancreatic enzymes from extracts of the pancreas of cattle and reindeer |
|
|
Karavaeva L., Krylova P., Moroz A., Kotova N., Glazova N., Bunyatyan N.
|
| 卷 68, 编号 3 (2019) |
Design and standardization of the composition of suppositories containing antiviral components |
|
|
Saenko A., Stepanova E., Lazaryan J., Petrov A., Kul I.
|
| 卷 68, 编号 8 (2019) |
Development of the composition and technology of vaginal suppositories containing a garden sage (Salvia officinalis) leaf extract |
|
|
Yunusova I., Perederiy Y.
|
| 卷 68, 编号 4 (2019) |
Development of composition and technology of granules with dry extracts of corn silk and roots of achyranthes bidentata |
|
|
Nguyen T., Ozhigova M., Kaukhova I., Vainshtein V.
|
| 卷 71, 编号 5 (2022) |
Development of a method for assessing drugs antiviral activity |
|
|
Imamaliev B., Shokodirov R.
|
| 卷 72, 编号 4 (2023) |
Development of anti-adhesion membrane technology for isolation of intestinal anastomosis |
|
|
Strusovskaya O., Rytchenkov S.
|
| 卷 72, 编号 1 (2023) |
Development of technology and study of the microbiological purity of dental gel |
|
|
Rizaeva N., Yunuskhojaeva N., Khusainova R., Yunuskhojieva N.
|
| 卷 69, 编号 8 (2020) |
Development of technology and procedures for analysis of rectal suppositories with phytoconstituents |
|
|
Saenko A., Stepanova E., Lazaryan J., Petrov A., Kul I., Denisenko O.
|
| 卷 69, 编号 8 (2020) |
The development of technology for therapeutic and prophylactic herbal toothpaste and its standardization |
|
|
Varina N., Kurkin V., Avdeeva E., Pervushkin S., Klimova L., Stenyaeva V., Zimenkina N.
|
| 卷 72, 编号 4 (2023) |
Development of technology for obtaining a dry extract from the Scutellaria Iscanderi Juz. herb |
|
|
Muratova S., Ismailova M., Ismailova P., Khalilov R.
|
| 卷 71, 编号 1 (2022) |
Development of a transdermal formulation based on nanocellulose |
|
|
Spatlova L., Petrov V., Gibadullin M., Averyanov N.
|
| 卷 71, 编号 6 (2022) |
Development of conditions for analytical diagnosis of poisoning with clopidogrel |
|
|
Anosova L.
|
| 卷 71, 编号 7 (2022) |
Development of a UV spectrophotometric method for quantitative determination of a clopidogrel metabolite suitable for chemical and toxicological analysis |
|
|
Anosova L., Remezova I., Agafonov A.
|
| 卷 70, 编号 1 (2021) |
Design of a pharmaceutical composition with a low-dose statin and a high lipid-lowering activity |
|
|
Bunyatyan N., Kozlova A., Balashov V., Balashov A., Kazakov R., Prokofyev A.
|
| 卷 69, 编号 1 (2020) |
Human mucosal immunity proteins recognizing glycoconjugates: the lectin systems of the probiotic biotope compartment in the body’s mucosal open cavities |
|
|
Lakhtin M., Lakhtin V., Aleshkin V., Afanasyev S.
|
| 卷 70, 编号 6 (2021) |
The distribution of clopidogrel in the organs of poisoned animals |
|
|
Anosova L.
|
| 卷 68, 编号 6 (2019) |
Rastitel'nyy preparat Femo-Klim: vozmozhnosti primeneniya |
|
|
- -.
|
| 卷 69, 编号 6 (2020) |
Regulatory aspects of preclinical and clinical trials of drugs |
|
|
Taube A.
|
| 卷 72, 编号 1 (2023) |
Regulation of the antioxidant defense system in the liver of white rats against the background of drug-induced hepatitis |
|
|
Baghirov I., Guliyeva S.
|
| 卷 70, 编号 2 (2021) |
Resource potential of Polygonum coriarium Grig. in the Varzob District of Tajikistan |
|
|
Sharifova S., Belonogova V., Kuritsyn A., Zagrebelnyi I.
|
| 卷 68, 编号 8 (2019) |
Retrospective analysis of the Russian veterinary drugs market |
|
|
Deltsov A., Kosova I.
|
| 卷 70, 编号 3 (2021) |
THE ROLE OF REAL CLINICAL PRACTICE DATA IN MODERN HEALTHCARE |
|
|
Novoderezhkina E., Zyryanov S.
|
| 卷 72, 编号 2 (2023) |
The role of building a unified approach to the pharmaceutical quality system for the harmonious development of the pharmaceutical industry in the EAEU |
|
|
Goryachkin V., Grigorova L., Gegechkori V., Chadova N., Rodionova G.
|
| 卷 72, 编号 3 (2023) |
Selenium and selenium-containing drugs: antioxidant and anti-aging effects, possibility of application in cardiology |
|
|
Dedov D.
|
| 卷 72, 编号 1 (2023) |
Selenium and selenium-containing drugs: biological and pharmacological effects on the human body |
|
|
Dedov D.
|
| 卷 70, 编号 8 (2021) |
Selenium and selenium-containing drugs: importance for the body and prevention of various diseases |
|
|
Dedov D.
|
| 卷 70, 编号 1 (2021) |
Synthesis of 2,6-dialkyl derivatives of pyrimidine-4 (1H)-one with an anti-inflammatory effect |
|
|
Kodonidi I., Anenko D., Terekhov A., Sidorskaya S., Grigoryants E.
|
| 卷 69, 编号 3 (2020) |
SYNTHESIS OF THE TRIPEPTIDE H-ProAla-Glu-OH AND AN INVESTIGATION OF ITS TOXICOLOGICAL PROPERTIES |
|
|
Bunyatyan N., Bobizoda G., Popova O., Sapovsky M., Samiev M., Prokofiev A., Remezova I., Evteev V.
|
| 卷 71, 编号 5 (2022) |
Therapeutic systems: characteristics, differential signs, assortment analysis |
|
|
Zhilyakova E., Avtina N., Bondarev A.
|
| 卷 72, 编号 3 (2023) |
Screening study of various immunomodulatory medicinal collections |
|
|
Imamaliev B., Alimkulova K., Shokodirov A., Urmanova F.
|
| 卷 71, 编号 4 (2022) |
Improving methodology approaches of pharmacists training in modern conditions |
|
|
Sergunova E., Bobkova N., Samylina I.
|
| 卷 72, 编号 5 (2023) |
The current state of knowledge of Ethiopian sage (Salvia aethiopis L.) |
|
|
Krymova A., Popova O.
|
| 卷 68, 编号 8 (2019) |
Current aspects of the use of excipients as exemplified by transdermal therapeutic system technology |
|
|
Shestakov N., Pyatigorskaya N.
|
| 卷 73, 编号 2 (2024) |
The modern approaches of analysis of dihydroquercetin stereoisomeric composition |
|
|
Terekhov R., Savina A., Pankov D., Nikitin I., Selivanova I.
|
| 卷 71, 编号 5 (2022) |
Modern approaches to the isolation and purification of active biological substances from reindeer organs |
|
|
Karavaeva L., Kotova N., Glazova N., Bunyatyan N., Evteev V., Prokofiev A.
|
| 卷 73, 编号 2 (2024) |
Modern drugs for nutritional support of the patient |
|
|
Morozov A., Sergeev A., Askerov E., Drozdova D., Markova P., Khodzhaeva S.
|
| 卷 69, 编号 2 (2020) |
Current problems with the standard samples of medicines in the Russian Federation |
|
|
Volkova R., Fadeikina O., Ustinnikova O., Sakanyan E., Merkulov V., Movsesyants A., Bondarev V., Olefir Y.
|
| 卷 71, 编号 2 (2022) |
Modern conservation methods of medicinal plant raw materials: variability of the content and stability of biologically active substances |
|
|
Ilina M., Sergunova E., Samylina I.
|
| 卷 69, 编号 8 (2020) |
Current trends in the development of the Russian market of crystalloid infusion solutions |
|
|
Trofimova E., Delvig-Kamenskaya T., Denisova M.
|
| 卷 68, 编号 4 (2019) |
A MODERN VIEW ON ALLERGIC RHINITIS: PATHOGENESIS, DIAGNOSIS, AND THERAPY |
|
|
Khadzhiyeva Z., Pozdnyakov D., Rybalko A., Lezhneva L., Aleynikova N.
|
| 卷 73, 编号 1 (2024) |
Modern methodological approach to the assessment of the individual quality of life of hiv-infected patients |
|
|
Petrov A., Glembotskaya G., Khoroshilova O.
|
| 卷 68, 编号 6 (2019) |
The content of tannins in the rhizomes of yellow iris (Iris pseudacorus) growing in the Moscow Region |
|
|
Sorokina A., Tikhomirova E., Kostikova E., Suleimanova F., Sokolskaya T.
|
| 卷 70, 编号 8 (2021) |
The content of macronutrients in the raw material of medicinal plants cultivated in the North-West of the Russian Federation |
|
|
Klemper A., Gravel I., Generalova Y., Luzhanin V.
|
| 卷 72, 编号 3 (2023) |
Phenolic compounds content in the raw material of Eleutherococcus senticosus Rupr. et Maxim |
|
|
Komarova A., Stepanova T., Prokopiev I., Mechikova A.
|
| 卷 71, 编号 6 (2022) |
Creation and technological research of dental gel with tizol and L-arginine |
|
|
Samoshina E., Stepanova E., Poroyskiy S., Saenko A.
|
| 卷 68, 编号 4 (2019) |
SORPTION AND DESORPTION OF LIQUID PLANT EXTRACT |
|
|
Gulenkov A., Mizina P.
|
| 卷 73, 编号 2 (2024) |
Composition of biologically active substances of common cranberry fruits (Oxycoccus palustris Pers.) in various methods of preservation |
|
|
Sergunova E., Malysheva M., Morokhina S., Samylina I.
|
| 卷 71, 编号 2 (2022) |
Composition of biologically active compounds of three-part beggarticks herb |
|
|
Rodin M., Bokov D., Samylina I.
|
| 卷 73, 编号 3 (2024) |
The composition and content of some vitamins in the leaves of European dewberry (Rubus caesius L.) and aqueous extracts based on them |
|
|
Ilina M., Sergunova E.
|
| 卷 70, 编号 2 (2021) |
The composition and pharmacological action of biologically active substances in the plants of the genus Ferula |
|
|
Popova O., Bobizoda G., Bunyatyan N., Remezova I., Samylina I., Prokofyev A., Evteev V., Sapovsky M.
|
| 卷 70, 编号 3 (2021) |
SPECTROPHOTOMETRIC DETERMINATION OF THE AMOUNT OF FLAVONOIDS IN SOME ASTRAGALUS SPECIES |
|
|
Matvienko U., Fomina Y., Shestopalova N., Berezutsky M., Durnova N.
|
| 卷 70, 编号 1 (2021) |
Comparison of Pharmacopoeial Requirements for the Quality of Fish Oil in USA and the Great Britain |
|
|
Lopatin V., Fetisova A.
|
| 卷 73, 编号 2 (2024) |
Comparative study of morphological and anatomical features of Bidens L. Species |
|
|
Rodin M., Baeva V., Bokov D., Voronov V., Samylina I.
|
| 卷 70, 编号 6 (2021) |
Comparative investigation of the efficacy of Cortexin®, Pineamine®, levilimab, adalimumab, and dexamethasone on cytokine storm models |
|
|
Kalatanova A., Trofimets E., Afanasieva A., Saparova V., Kryshen K., Makarenko I.
|
| 卷 71, 编号 1 (2022) |
Comparative study of the anatomical and morphological features of common ivy leaves from various habitats |
|
|
Solodukhina A., Gudkova A., Brezhnev T., Slivkin A.
|
| 卷 68, 编号 3 (2019) |
Comparative analysis of biologically active compounds of homeopathic matrix tinctures from dried and fresh horse gowan (Matricaria chamomilla) herb |
|
|
Poklonskaya A., Strelyaeva A., Luferov A., Kuznetsov R.
|
| 卷 69, 编号 7 (2020) |
Stake on transfer: evolution of a regulatory framework for the development of the pharmaceutical industry |
|
|
Rudko A., Konikov D., Sidorov K., Ilyinova J.
|
| 卷 69, 编号 3 (2020) |
STANDARDIZATION OF AN ANALYTICAL PHARMACIST'S WORK: METHODOLOGICAL APPROACHES |
|
|
Strelkov S., Strelkova V., Zolotareva N.
|
| 卷 68, 编号 5 (2019) |
STANDARDIZATION OF THE COMPOSITION OF GROWTH SUBSTRATES FOR OBTAINING AN ANTIFUNGAL ANTIBIOTIC |
|
|
Yakovleva E., Kolodyaznaya V., Topkova O.
|
| 卷 69, 编号 8 (2020) |
Standardization of Canadian goldenrod (Solidago canadensis) herb |
|
|
Suloev I., Ponkratova A., Dudetskaya N., Teslov L., Luzhanin V.
|
| 卷 71, 编号 7 (2022) |
Formation and development of the biopharmaceutical doctrine of creating effective medicines |
|
|
Demina N., Bardakov A., Krasniuk I.
|
| 卷 71, 编号 7 (2022) |
Theoretical and practical development of the composition of intranasal dosage forms with the active component of ginko biloba extract |
|
|
Kovtun E., Stepanova E., Pogrebnyak L., Glizhova T., Pogrebnyak A., Bokov D.
|
| 201 - 300 的 336 信息 |
<< < 1 2 3 4 > >> |
